SCHEDULE 13G/A: Austin Che Reduces Stake in Ginkgo Bioworks Holdings, Files Exit Schedule 13G

Austin Che, a reporting person, has filed an Amendment No. 4 to Schedule 13G, indicating he is no longer a beneficial owner of more than five percent of Ginkgo Bioworks Holdings, Inc.'s Class A Common Stock as of December 31, 2024.

Summary

• This document is Amendment No. 4 to Schedule 13G filed by Austin Che concerning his beneficial ownership in Ginkgo Bioworks Holdings, Inc.
• The filing serves as an "exit filing," signifying that Austin Che has ceased to be the beneficial owner of more than 5% of the outstanding Class A Common Stock.
• As of December 31, 2024, Austin Che beneficially owned 2,372,573 shares of Class A Common Stock.
• This ownership represents 5.0% of the Class A Common Stock outstanding.
• The beneficial ownership calculation is based on 45,575,423 shares of Class A Common Stock outstanding as of December 31, 2024, plus 2,003,679 shares of Class A Common Stock issuable upon conversion of Class B Common Stock beneficially owned by the Reporting Person.
• Austin Che holds sole voting power and sole dispositive power over all 2,372,573 shares.
• The shares are held through various entities, including direct ownership of Class A shares (318,894 shares), a revocable spousal trust (25,000 shares), a family trust (25,000 shares), the Austin Che Revocable Trust (1,923,175 Class B convertible shares), the Austin Che Irrevocable Trust (20,555 Class B convertible shares), an irrevocable marital trust (1,944 Class B convertible shares), and direct ownership of Class B convertible shares (58,005 shares).

Sentiment

Score: 5

Explanation: The filing is a routine compliance update indicating a change in beneficial ownership, specifically that Austin Che's stake in Ginkgo Bioworks Holdings, Inc. has fallen to 5.0%, triggering an exit filing. This type of filing is generally neutral in sentiment as it reflects a change in an individual's investment position rather than a direct operational or financial performance update for the company.

Positives

• The filing is a routine compliance update, indicating a change in beneficial ownership rather than a negative operational event for the company.
• The reporting person certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Negatives

• A reduction in a significant insider's stake, even if just below a threshold, could be perceived as a slight negative by some investors, though the document provides no specific reason for the reduction.

Future Outlook

NA

Industry Context

This filing is a standard regulatory disclosure of a change in insider ownership and does not provide specific insights into broader industry trends or competitive dynamics for the synthetic biology sector.

Stakeholder Impact

• Shareholders: May interpret the reduction in insider stake differently; some may view it as a routine portfolio adjustment, while others might perceive it as a minor negative signal.

Key Dates

Keywords

Ginkgo Bioworks Holdings, Austin Che, Schedule 13G, Beneficial Ownership, Class A Common Stock, SEC Filing, Insider Ownership, Exit Filing, Biotechnology, Synthetic Biology